ATE94396T1 - N-acetylneuraminsaeure enthaltende expektorantien. - Google Patents

N-acetylneuraminsaeure enthaltende expektorantien.

Info

Publication number
ATE94396T1
ATE94396T1 AT91100080T AT91100080T ATE94396T1 AT E94396 T1 ATE94396 T1 AT E94396T1 AT 91100080 T AT91100080 T AT 91100080T AT 91100080 T AT91100080 T AT 91100080T AT E94396 T1 ATE94396 T1 AT E94396T1
Authority
AT
Austria
Prior art keywords
expectorants
acetylneuraminic acid
expectorant
acid
acetyineuramin
Prior art date
Application number
AT91100080T
Other languages
English (en)
Inventor
Sadanori Ogasawara
Takashi Hanafusa
Katsuhide Kariya
Masayoshi Ito
Yoshiyasu Shitori
Original Assignee
Kanto Ishi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanto Ishi Pharma Co Ltd filed Critical Kanto Ishi Pharma Co Ltd
Application granted granted Critical
Publication of ATE94396T1 publication Critical patent/ATE94396T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT91100080T 1984-09-11 1985-09-10 N-acetylneuraminsaeure enthaltende expektorantien. ATE94396T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59189950A JPS6168418A (ja) 1984-09-11 1984-09-11 去痰薬
EP91100080A EP0429430B1 (de) 1984-09-11 1985-09-10 N-Acetylneuraminsäure enthaltende Expektorantien

Publications (1)

Publication Number Publication Date
ATE94396T1 true ATE94396T1 (de) 1993-10-15

Family

ID=16249907

Family Applications (2)

Application Number Title Priority Date Filing Date
AT85111414T ATE111738T1 (de) 1984-09-11 1985-09-10 N-acetylneuraminsäure und deren salze enthaltende expektorantien.
AT91100080T ATE94396T1 (de) 1984-09-11 1985-09-10 N-acetylneuraminsaeure enthaltende expektorantien.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT85111414T ATE111738T1 (de) 1984-09-11 1985-09-10 N-acetylneuraminsäure und deren salze enthaltende expektorantien.

Country Status (14)

Country Link
US (1) US4698332A (de)
EP (2) EP0177783B1 (de)
JP (1) JPS6168418A (de)
KR (1) KR880001234B1 (de)
CN (1) CN85108388B (de)
AT (2) ATE111738T1 (de)
AU (1) AU582584B2 (de)
CA (1) CA1246452A (de)
DE (2) DE3587928T2 (de)
DK (1) DK165046C (de)
ES (1) ES8606323A1 (de)
FI (1) FI83963C (de)
HU (2) HU198733B (de)
ZA (1) ZA856905B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61289037A (ja) * 1985-06-14 1986-12-19 Mect Corp 新規去痰薬
GB8519416D0 (en) * 1985-08-01 1985-09-04 Unilever Plc Oligosaccharides
JP2573594B2 (ja) * 1987-03-06 1997-01-22 メクト株式会社 Ｎーアセチルー３ーフルオローノイラミン酸誘導体およびその製造方法
US5843445A (en) * 1987-06-24 1998-12-01 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
JP2517293B2 (ja) * 1987-06-25 1996-07-24 メクト株式会社 細胞、組織修復剤
US5393742A (en) * 1990-08-30 1995-02-28 Mect Corporation Preparation for treating renal disease
US5514665A (en) * 1993-12-30 1996-05-07 University Of British Columbia Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
AUPM411494A0 (en) * 1994-02-25 1994-03-24 Central Sydney Area Health Service Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum
US5856446A (en) * 1995-07-07 1999-01-05 Autoimmune Inc. Method of treating rheumatoid arthritis with low dose type II collagen
AUPQ275799A0 (en) 1999-09-10 1999-10-07 Luminis Pty Limited Recombinant bacterium expressing an oligosaccharide receptor mimic
JP4005115B1 (ja) 2007-02-08 2007-11-07 日本臓器製薬株式会社 疼痛疾患治療剤
US9241896B2 (en) * 2008-12-19 2016-01-26 Ultragenyx Pharmaceutical Inc. Methods and formulations for treating sialic acid deficiencies
UA110325C2 (en) 2009-07-03 2015-12-25 Australian Biomedical Company Pty Ltd Medicinal carbohydrates for treating respiratory conditions
CA2805222A1 (en) 2010-07-13 2012-01-19 Ultragenyx Pharmaceutical Inc. Methods and formulations for treating sialic acid deficiencies
ES2807890T3 (es) 2011-10-24 2021-02-24 Ultragenyx Pharmaceutical Inc Análogos de ácido siálico
WO2014151526A1 (en) 2013-03-15 2014-09-25 Huiru Wang Biological therapeutics for infection-relating disorders or conditions
WO2014151523A1 (en) 2013-03-15 2014-09-25 Huiru Wang Compositions and products for infectious or inflammatory diseases or conditions
WO2016017677A1 (ja) * 2014-07-30 2016-02-04 協和発酵バイオ株式会社 Ｎ－アセチルノイラミン酸アルカリ金属塩・無水和物の結晶及びその製造方法
KR102646509B1 (ko) * 2015-01-28 2024-03-11 교와 핫꼬 바이오 가부시키가이샤 N-아세틸노이라민산암모늄염·무수화물의 결정 및 그 제조 방법
TW201720803A (zh) 2015-09-14 2017-06-16 超基因克斯製藥公司 唾液酸或其鹽或溶劑合物之晶型
CN109771316B (zh) * 2018-12-29 2022-02-25 中国科学院合肥物质科学研究院 一种提高n-乙酰神经氨酸水溶液稳定性的方法及其应用
CN110606864B (zh) * 2019-10-08 2023-10-10 中国科学院合肥物质科学研究院 一种n-乙酰神经氨酸钙盐晶体及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1177863B (it) * 1984-07-03 1987-08-26 Fidia Farmaceutici Una miscela gangliosidica come agente terapeutico capare di eliminare il dolore nele neuropatie periferiche
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
IT1182209B (it) * 1985-02-18 1987-09-30 Fidia Farmaceutici Uso terapeutico del monosialoganglioside gm1 e dei suoi derivati in gravi patologie di infarti cerebrali

Also Published As

Publication number Publication date
DE3587928T2 (de) 1995-01-26
DK413785D0 (da) 1985-09-11
AU582584B2 (en) 1989-04-06
AU4719985A (en) 1986-03-20
DK165046C (da) 1993-02-22
FI83963C (fi) 1991-09-25
JPS6328411B2 (de) 1988-06-08
HU198733B (en) 1989-11-28
HU197515B (en) 1989-04-28
FI853456A0 (fi) 1985-09-10
DE3587928D1 (de) 1994-10-27
DK165046B (da) 1992-10-05
DE3587587T2 (de) 1994-03-31
EP0429430A2 (de) 1991-05-29
JPS6168418A (ja) 1986-04-08
CA1246452A (en) 1988-12-13
EP0177783A2 (de) 1986-04-16
KR880001234B1 (ko) 1988-07-12
HUT40804A (en) 1987-02-27
CN85108388B (zh) 1988-08-24
ZA856905B (en) 1986-06-25
KR860002525A (ko) 1986-04-26
US4698332A (en) 1987-10-06
ATE111738T1 (de) 1994-10-15
FI853456L (fi) 1986-03-12
ES546840A0 (es) 1986-04-16
EP0429430B1 (de) 1993-09-15
CN85108388A (zh) 1987-06-03
EP0177783A3 (en) 1989-02-22
FI83963B (fi) 1991-06-14
EP0177783B1 (de) 1994-09-21
DE3587587D1 (de) 1993-10-21
DK413785A (da) 1986-03-12
ES8606323A1 (es) 1986-04-16
EP0429430A3 (en) 1991-10-23

Similar Documents

Publication Publication Date Title
ATE94396T1 (de) N-acetylneuraminsaeure enthaltende expektorantien.
DE3671367D1 (de) Arzneistoffadsorbate und deren herstellung.
FI884387A7 (fi) Uudentyyppiset geelikoosteet.
DE3684542D1 (de) Acylcarnitine als absorptionsbeschleuniger fuer die wirkstoffverabreichung ueber die schleimhaeute der nasen-, mund-, sublingual- und vaginalhoehle.
NO872685D0 (no) Nye topisk appliserbare farmasoeytiske sammensetninger med systemisk virkning.
EP0276543A3 (de) Verwendung von Buspiron zur Verbesserung des Kurzzeitgedächtnisses
NO173653C (no) Analogifremgangsmaate for fresmstilling av terapeutisk aktive 6-benzoksazinyl-og 6-benzotianzinyl-2,3,4,5-tetrahydropyridazin-3-oner
NO167660C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylmetylazoler og salter derav.
DE3680000D1 (de) Stabilisierte aktive formen von vitamin-d3.
AU5284286A (en) Antiinflammatory composition of inositol and piroxicam
DK166343C (da) Forbedret piroxicamholdigt laegemiddel
FR2617502B1 (fr) Preparation enzymatique d'anhydro-1,5 d fructose
NO871190D0 (no) Fremgangsmaate for fremstilling av farmakologisk aktive substituerte anilider.
FI853343A7 (fi) Menetelmä farmaseuttisesti aktiivisten fenyyli-asetonitriilijohdannaisten valmistamiseksi.
FI862566A0 (fi) Foerfarande foer framstaellning av nya penemderivat.
IT8619594A0 (it) Acid 8-osso-2-ossa-1-azabiciclo 4.2.0 ottano-3-carbossilici.
TR23253A (tr) Zorunlu olarak sodyum suelfat meydana gelmeden parafin-sulfoksidasyon-reaksiyon karisimlarindan alkali suelfat bakimindan fakir parafin suelfonot'larinin ve suelfuerik asidin izde edilmesine mahsus usul
IT8720800A0 (it) Composto attivo nella terapia carciovascolare.
OA06185A (fr) Nouvelles compositions pharmaceutiques à base d'enzyme bactérien.
IT8819447A0 (it) Composizione di composti che migliorano l'attivita' analgesica, antipiretica e antinfiammatoria.
IT8520282A0 (it) Procedimento per migliorare le proprieta' del cemento, e cemento cosi' ottenuto.
IT8506952V0 (it) Staffa con duplice azione di ferma-coppi e ferma-neve.
IT8721769A0 (it) Tioderivati beta-lattamici farmacologicamente attivi eprocedimento per la loro preparazione.
IT8520437A0 (it) Immino-imidazolidine sostituite, dotate di particolari proprieta'terapeutiche loro processo disintesi e composizioni farmaceutiche.
FI871533A0 (fi) Daeck med infaellda dubbar.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee